May 22, 2014
Prostate cancer (cancer in tissues of the prostate gland, located between the bladder and the penis) is reported less frequently among HIV-positive men than their HIV-negative counterparts -- but is this due to lower actual incidence, or to lower rates of screening for prostate cancer?
To address this question, Julia L. Marcus of the Kaiser Permanente Northern California Division of Research and colleagues conducted a cohort study comparing prostate cancer rates in HIV-positive and HIV-negative men receiving care at Kaiser medical centers in California.
As reported May 12, 2014, in a published-ahead-of-print online edition of the Journal of Acquired Immune Deficiency Syndromes, the study included 17,424 HIV-positive and 182,799 HIV-negative men. Participants in Northern California were in care at Kaiser facilities between 2000 and 2007, and Southern California participants were in care between 1996 and 2007.
This excerpt was cross-posted with the permission of BETAblog.org. Read the full article.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.